Viewing StudyNCT00110188



Ignite Creation Date: 2024-05-05 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00110188
Status: COMPLETED
Last Update Posted: 2015-11-20
First Post: 2005-05-04

Brief Title: Ridaforolimus AP23573MK-8669 in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer AIPCMK-8669-017
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Organization Data

Organization: Merck Sharp Dohme LLC
Class: INDUSTRY
Study ID: 8669-017
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Merck Sharp Dohme LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Ariad Pharmaceuticals INDUSTRY